0.4534
price up icon6.98%   0.0296
 
loading
Biodesix Inc stock is traded at $0.4534, with a volume of 1.87M. It is up +6.98% in the last 24 hours and up +25.94% over the past month. Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
See More
Previous Close:
$0.4238
Open:
$0.4238
24h Volume:
1.87M
Relative Volume:
0.24
Market Cap:
$66.48M
Revenue:
$49.09M
Net Income/Loss:
$-52.15M
P/E Ratio:
-0.6975
EPS:
-0.65
Net Cash Flow:
$-45.93M
1W Performance:
+14.41%
1M Performance:
+25.94%
6M Performance:
-48.59%
1Y Performance:
-74.24%
1-Day Range:
Value
$0.41
$0.4599
1-Week Range:
Value
$0.3844
$0.4599
52-Week Range:
Value
$0.1718
$2.04

Biodesix Inc Stock (BDSX) Company Profile

Name
Name
Biodesix Inc
Name
Phone
303-417-0500
Name
Address
919 WEST DILLON ROAD, LOUISVILLE
Name
Employee
273
Name
Twitter
Name
Next Earnings Date
2025-03-03
Name
Latest SEC Filings
Name
BDSX's Discussions on Twitter

Compare BDSX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
BDSX
Biodesix Inc
0.4534 62.32M 49.09M -52.15M -45.93M -0.65
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
499.99 184.10B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
211.80 149.66B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
645.55 51.03B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
121.63 33.56B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
191.15 32.73B 15.70B 1.24B 2.01B 6.91

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Date Action Analyst Rating Change
May-14-25 Downgrade William Blair Outperform → Mkt Perform
Sep-16-24 Initiated Scotiabank Sector Outperform
Jul-26-24 Initiated Craig Hallum Buy
May-13-24 Initiated TD Cowen Buy
May-03-24 Initiated Lake Street Buy
Nov-17-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-23-20 Initiated BTIG Research Buy
Nov-23-20 Initiated Canaccord Genuity Buy
Nov-23-20 Initiated Morgan Stanley Overweight
Nov-23-20 Initiated William Blair Outperform
View All

Biodesix Inc Stock (BDSX) Latest News

pulisher
Aug 20, 2025

Fibonacci Support Holding Strong in Biodesix Inc.July 2025 Institutional & Weekly Sector Rotation Insights - classian.co.kr

Aug 20, 2025
pulisher
Aug 20, 2025

Will Biodesix Inc. Reverse From Oversold ConditionsQuarterly Performance Summary & AI Based Buy and Sell Signals - beatles.ru

Aug 20, 2025
pulisher
Aug 20, 2025

Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics - GlobeNewswire

Aug 20, 2025
pulisher
Aug 19, 2025

Biodesix Designated Thermo Fisher Center of Excellence for NGS-Based Diagnostics. - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Biodesix Validates Thermo Fisher's Oncomine Dx Express Test for Solid Tumors on Genexus Dx Integrated Sequencer. - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Major Diagnostic Partnership: Biodesix Joins Elite Group as Thermo Fisher Center of Excellence for Cancer Testing - Stock Titan

Aug 19, 2025
pulisher
Aug 18, 2025

Wyckoff Accumulation Phase Possible in Biodesix Inc.July 2025 Review & Long-Term Growth Stock Strategies - newsimpact.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

Options Data Show Bullish Bias in Biodesix Inc.July 2025 Breakouts & AI Enhanced Market Trend Forecasts - newsyoung.net

Aug 18, 2025
pulisher
Aug 17, 2025

Biodesix, Inc. Reports Strong Q2 2025 Growth - MSN

Aug 17, 2025
pulisher
Aug 17, 2025

What makes Biodesix Inc. stock price move sharplyBond Market & Short-Term Trading Alerts - thegnnews.com

Aug 17, 2025
pulisher
Aug 17, 2025

Biodesix Inc. Stocks Attracting Dip BuyersJuly 2025 Macro Moves & AI Enhanced Market Trend Forecasts - newsyoung.net

Aug 17, 2025
pulisher
Aug 16, 2025

Is This the Dip to Buy in Biodesix Inc.Wall Street Watch & AI Driven Price Predictions - newsimpact.co.kr

Aug 16, 2025
pulisher
Aug 15, 2025

What MACD and RSI say about Biodesix Inc.Portfolio Risk Summary & Weekly Breakout Watchlists - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Biodesix (NASDAQ:BDSX) Releases Earnings Results - MarketBeat

Aug 15, 2025
pulisher
Aug 15, 2025

Combining machine learning predictions for Biodesix Inc.2025 Technical Patterns & Risk Managed Investment Signals - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Price momentum metrics for Biodesix Inc. explainedJuly 2025 Decliners & Smart Money Movement Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Combining price and volume data for Biodesix Inc.Quarterly Profit Review & Community Verified Watchlist Alerts - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

AI Indicators Detect Buy Opportunity in Biodesix Inc.CEO Change & Fast Entry and Exit Trade Plans - kangso.co.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Can Biodesix Inc. Outperform Peers After Recent PullbackExit Point & Proven Capital Preservation Methods - thegnnews.com

Aug 14, 2025
pulisher
Aug 14, 2025

Will Biodesix Inc. Benefit From Sector TailwindsTrade Performance Summary & Low Volatility Stock Recommendations - newsimpact.co.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Blair William & Co. IL Has $78,000 Stake in Biodesix, Inc. (NASDAQ:BDSX) - Defense World

Aug 14, 2025
pulisher
Aug 14, 2025

Is a relief rally coming for Biodesix Inc. holders2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Will Biodesix Inc. bounce back from current supportFed Meeting & Risk Managed Investment Strategies - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Earnings visualization tools for Biodesix Inc.2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Biodesix at Canaccord Conference: Strategic Expansion in Diagnostics By Investing.com - Investing.com Canada

Aug 12, 2025
pulisher
Aug 12, 2025

Is Biodesix Inc. a strong growth stockUndervalued High Return Candidates - kangso.co.kr

Aug 12, 2025
pulisher
Aug 12, 2025

Investors Still Aren't Entirely Convinced By Biodesix, Inc.'s (NASDAQ:BDSX) Revenues Despite 26% Price Jump - 富途牛牛

Aug 12, 2025
pulisher
Aug 12, 2025

Biodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 12, 2025
pulisher
Aug 10, 2025

Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price - 富途牛牛

Aug 10, 2025
pulisher
Aug 10, 2025

Should I add Biodesix Inc. stock to my portfolioMulti-Year Breakout Candidates - thegnnews.com

Aug 10, 2025
pulisher
Aug 10, 2025

Earnings Release: Here's Why Analysts Cut Their Biodesix, Inc. (NASDAQ:BDSX) Price Target To US$1.80 - Yahoo Finance

Aug 10, 2025
pulisher
Aug 08, 2025

Biodesix 2025 Q2 Earnings Revenue Grows 11.7% Amid Expanding Losses - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Biodesix reports strong Q2 revenue growth - BizWest

Aug 08, 2025
pulisher
Aug 08, 2025

Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 08, 2025
pulisher
Aug 08, 2025

Biodesix, Inc. shares fall 9.84% intraday despite Q2 revenue beating estimates. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Transcript : Biodesix, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

Biodesix Plunges 11.63% on Q2 Loss, Revenue Surprise - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Biodesix Reports Strong Q2 2025 Revenue Growth - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

Biodesix Maintains Hold Rating Amid Revenue Growth and Cash Flow Challenges - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansion ... By GuruFocus - Investing.com Canada

Aug 08, 2025
pulisher
Aug 08, 2025

Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Gr - GuruFocus

Aug 08, 2025
pulisher
Aug 08, 2025

Biodesix Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 08, 2025
pulisher
Aug 07, 2025

Biodesix Outpaces Expectations With Lung Test Growth And Upbeat Outlook - Finimize

Aug 07, 2025
pulisher
Aug 07, 2025

Diagnostic firm Biodesix Q2 revenue beats estimates - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Biodesix earnings missed, revenue topped estimates By Investing.com - Investing.com South Africa

Aug 07, 2025
pulisher
Aug 07, 2025

Biodesix earnings missed, revenue topped estimates - Investing.com

Aug 07, 2025
pulisher
Aug 07, 2025

Biodesix Announces Second Quarter 2025 Results and Highlights - The Manila Times

Aug 07, 2025
pulisher
Aug 07, 2025

Biodesix Soars 14.1% on Conference Presentation - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Biodesix Stock Soars 12.82% on Strong Q1 Earnings - AInvest

Aug 07, 2025

Biodesix Inc Stock (BDSX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Biodesix Inc Stock (BDSX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Hutton Scott
President & CEO
Aug 13 '25
Sale
0.42
3,772
1,570
728,824
O'Kane Kieran
Chief Commercial Officer
Aug 13 '25
Sale
0.42
476
198
140,065
Pestano Gary Anthony
Chief Development Officer
Aug 13 '25
Sale
0.42
442
184
157,878
Vazquez Chris
Chief Accounting Officer
Aug 13 '25
Sale
0.42
228
95
18,375
SCHULER JACK W
Director
May 16 '25
Buy
0.27
4,000,000
1,070,000
20,194,935
SCHULER JACK W
Director
May 19 '25
Buy
0.34
723,239
246,624
20,918,174
Vazquez Chris
Chief Accounting Officer
May 12 '25
Sale
0.36
112
40
18,113
Vazquez Chris
Chief Accounting Officer
May 13 '25
Sale
0.35
112
40
18,001
Pestano Gary Anthony
Chief Development Officer
May 12 '25
Sale
0.36
223
80
157,163
Pestano Gary Anthony
Chief Development Officer
May 13 '25
Sale
0.35
222
78
156,941
diagnostics_research WAT
$302.19
price up icon 4.05%
diagnostics_research DGX
$180.23
price down icon 1.90%
$165.60
price up icon 2.25%
diagnostics_research LH
$278.18
price up icon 0.59%
diagnostics_research MTD
$1,321.45
price up icon 3.40%
diagnostics_research IQV
$191.15
price up icon 3.11%
Cap:     |  Volume (24h):